1. Switzerland Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Sonova Holding AG

Sonova Holding AG

304.00
EUR
+6.20
(+2.08%)
11.63BMarket Cap
Nov 12Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
28.88
30.14
31.21
36.43
40.24
42.19
45.62
41.32
54.02
62.07
60.82
60.62
60.53
- -
Basic EPS, GAAP
5.04
5.33
5.08
5.31
6.08
6.93
7.56
9.23
10.42
10.75
10.08
9.07
7.23
- -
Free Cash Flow per Basic Share
4.68
5.49
5.2
6.45
7.96
8.14
11.18
10.72
13.4
10.45
10.48
11.05
10.61
- -
Dividend per Share
1.59
1.89
2.05
2.09
2.29
2.59
2.92
- -
3.24
4.44
4.6
4.3
4.4
- -
Book Value per Share
25.81
27.5
28.58
32.02
37.28
36.33
32
43.59
39.46
37.12
41.44
44.7
44
44
Tangible Book Value per Share
8.63
9.32
8.09
-3.26
-0.22
-1.69
-6.51
5.17
-8.81
-14.19
-9.53
-5.37
-0.12
-0.12
Basic Weighted Avg Shares
68
68
66
66
66
66
64
63
62
60
60
60
60
60
Sales/Revenue/Turnover
1,951
2,035
2,072
2,396
2,646
2,763
2,917
2,602
3,364
3,738
3,627
3,613
3,606
- -
Operating Margin (%)
20.71
21.08
19.05
17.69
18.05
19.39
17.48
19.03
22.6
19.98
18.47
19.92
18.74
- -
Depreciation Expense
83
85
89
147
135
128
200
223
211
240
246
233
260
- -
Net Income, GAAP
341
360
337
349
400
454
483
581
649
648
601
541
431
- -
Effective Tax Rate (%)
11.96
12.37
12.9
14.65
14.93
13.1
2.57
2.53
8.86
8.02
5.84
17.45
14.91
- -
Profit Margin (%)
17.47
17.69
16.27
14.58
15.12
16.43
16.57
22.33
19.29
17.32
16.57
14.96
11.94
- -
Working Capital
507
569
499
532
582
282
118
1,368
154
409
515
411
895
895
LT Debt
- -
- -
- -
759
609
360
767
1,410
1,080
1,736
1,715
1,328
1,525
1,525
Total Equity
1,774
1,872
1,906
2,131
2,475
2,376
2,029
2,773
2,433
2,231
2,491
2,685
2,636
2,636
Return on Invested Capital (%)
18.75
19.59
17.92
14.58
12.99
14.49
15.83
15.3
15.81
16.65
14.57
13.11
12.73
- -
Return on Capital (%)
18.31
19.01
17.44
14.33
12.88
14.47
15.92
15.44
15.35
16.53
14.86
12.74
10.15
- -
Return on Common Equity (%)
20.3
20.06
18.09
17.5
17.55
18.9
22.14
24.42
25.16
28.01
25.67
21.05
16.32
- -

Capital Structure

CHF

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
ST Debt
432
65
186
LT Borrowings
1,148
- -
1,353
LT Finance Leases
180
162
173
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
60
60
59
Market Capitalization
- -
12,850
10,738

Working Capital

CHF

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
Total Current Assets
1,911
1,655
2,084
Cash, Cash Equivalents & STI
687
511
722
Accounts Receivable, Net
577
529
527
Inventories
469
441
381
Total Current Liabilities
1,500
1,336
1,189
Payables & Accruals
- -
- -
- -
ST Debt
432
65
186
Deferred Revenue
- -
- -
- -

Growth Rates

CHF

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.3%
-0.59%
-1.81%
Free Cash Flow
7.62%
-0.08%
-4.07%
Net Income, GAAP
3.22%
-5.22%
-20.33%
Sales/Revenue/Turnover
6.21%
7.37%
-0.19%
Total Cash Common Dividend
10,066.44%
20,146.2%
2.38%

Semi-annual Revenue

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
3,627
2025
- -
- -
3,613
2026
- -
- -
3,606

Semi-annual Earnings Per Share

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
10.08
2025
- -
- -
9.07
2026
- -
- -
7.23

Semi-annual Dividends Per Share

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
4.6
2025
- -
- -
4.3
2026
- -
- -
4.4

Company Description

Company Profile APIChatGPT
CEO
Eric Alain Bernard
Full Time Employees
18,447
Sector
Health technology
Industry
Medical specialties
Address
Laubisrütistrasse 28 Stäfa ZH Switzerland 8712
IPO Date
Apr 23, 2009
Website
sonova.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Sonova Holding AG, a leading provider of innovative hearing care solutions, engages in the design, manufacture, distribution, and sale of hearing instruments and related services. Main products and services include hearing aids across disposable, reusable, and premium lines; cochlear implant systems; bone-anchored and wireless accessories; hearing protection and patient care devices; professional diagnostic and fitting software; and aftercare services such as fitting, repairs, and remote care solutions. The company operates through core brands and product families in hearing health, with professional channels serving audiology clinics, hearing care professionals, and end customers. Latest major company changes include strategic partnerships and alliances in audiology technology, expansion of direct-to-consumer and professional channels, acquisitions and investments in innovative hearing solutions and related accessories, and launches of new product generations and software platforms. The company reports recent reorganizations and operational enhancements to support global distribution, R&D, and digital health initiatives, along with geographic expansion activities. Industry and business segments focus on hearing care and optically linked health technologies with geographic operations spanning Europe, North America, Asia-Pacific, and other regions. Founding year is 1946 with headquarters in Staefa-Zh, Switzerland. Sonova maintains subsidiaries and brand-level operations worldwide, including affiliated entities within its global corporate structure. The company emphasizes advanced audiology products, patient-centered care, and scalable hearing care solutions for diverse customer groups, including individual consumers, clinics, and healthcare providers.

Company News

Company News APIChatGPT

  • reuters.com

    Sonova unveils new AI-powered hearing-aid platform to support growth targets

  • seekingalpha.com

    Sonova Holding AG (SONVY) Q4 2026 Earnings Call Transcript

  • seekingalpha.com

    Sonova Holding AG (SONVY) Discusses Refreshed Strategy and Vision for Next Phase of Growth Transcript

  • reuters.com

    Sonova expects FY revenue at lower end of target range, CEO says in interview

  • seekingalpha.com

    Sonova Holding AG (SONVY) Q2 2026 Earnings Call Transcript

  • seekingalpha.com

    Sonova Holding AG (SONVF) Q4 2025 Earnings Call Transcript

  • wsj.com

    Sonova Shares Jump on Sales Beat, CEO Change

  • seekingalpha.com

    Sonova Holding AG (SONVF) Q2 2025 Earnings Call Transcript